Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
November 10th, 2014
24.8K views
Substernal thyroid lesions are common, and need to be differentiated from malignancy. Obtaining percutaneous fine needle biopsy is not possible due to its retrosternal location. This article proposes a protocol for biopsy of substernal thyroid lesions using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA).
Overview
This article presents a protocol for performing biopsies on substernal thyroid lesions using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA). The procedure is essential for differentiating benign from malignant lesions when conventional biopsy methods are not feasible.
Key Study Components
Area of Science
- Neuroscience
- Medical Procedures
- Oncology
Background
- Substernal thyroid lesions are prevalent and require careful evaluation.
- Conventional percutaneous fine needle biopsy is often not possible due to the lesions' location.
- Endobronchial ultrasound provides a minimally invasive approach for biopsy.
- Accurate diagnosis is critical for appropriate patient management.
Purpose of Study
- To outline a reliable protocol for biopsy of substernal thyroid lesions.
- To enhance diagnostic accuracy using EBUS-TBNA.
- To improve patient outcomes by differentiating between benign and malignant lesions.
Methods Used
- Initial evaluation using conventional bronchoscopy to rule out endoluminal lesions.
- Deployment of an endobronchial ultrasound-guided bronchoscope.
- Ultrasound localization of the lesion and identification of a biopsy entry point.
- Collection of samples via transbronchial needle aspiration under real-time ultrasound guidance.
Main Results
- Successful identification and biopsy of substernal thyroid lesions.
- Real-time ultrasound guidance improves accuracy of sample collection.
- Preliminary cytopathology results assist in determining lesion nature.
- Post-procedure surveillance is essential for patient safety.
Conclusions
- EBUS-TBNA is a valuable technique for biopsying substernal thyroid lesions.
- The protocol enhances diagnostic capabilities in challenging cases.
- Further studies may solidify the role of EBUS-TBNA in clinical practice.
Frequently Asked Questions
What is EBUS-TBNA?
EBUS-TBNA stands for Endobronchial Ultrasound-guided Transbronchial Needle Aspiration, a technique used for biopsying lesions.
Why is conventional biopsy not suitable for substernal thyroid lesions?
Due to their retrosternal location, conventional percutaneous fine needle biopsy is often not feasible.
How does ultrasound guidance improve the biopsy procedure?
Ultrasound guidance allows for real-time visualization of the lesion, enhancing the accuracy of sample collection.
What are the benefits of rapid onsite cytopathology?
Rapid onsite cytopathology provides immediate feedback on the adequacy of samples and preliminary assessment of malignancy.
What steps are involved in the EBUS-TBNA procedure?
The procedure includes ruling out endoluminal lesions, locating the target lesion with ultrasound, and performing the biopsy.
What is the significance of post-procedure surveillance?
Post-procedure surveillance is crucial for monitoring patient recovery and detecting any complications early.
Executive Industry Relevance
Substernal thyroid lesions present diagnostic challenges due to anatomical constraints that limit conventional biopsy approaches, creating a need for minimally invasive alternatives. EBUS-TBNA offers a pathway to obtain tissue samples from airway-adjacent mediastinal structures without surgical intervention, reducing procedural morbidity and healthcare costs. This capability supports early differentiation of benign versus malignant pathology, informing risk-stratified management decisions in oncology and endocrinology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of thyroid lesion biology in anatomically inaccessible locations, supporting target validation in mediastinal disease models.
- Operational Value: Provides a reproducible method for sampling substernal tissues, facilitating consistent biomarker analysis across preclinical studies.
Screening & Assay Development
- Scientific Value: Generates cytological and histological samples suitable for downstream molecular profiling and assay development.
- Operational Value: Standardizes sample acquisition under real-time imaging guidance, improving pre-analytical variability in biomarker workflows.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant sampling of thyroid pathology models, enabling correlation of imaging findings with histopathological endpoints.
- Operational Value: Facilitates longitudinal monitoring of lesion response in preclinical studies through repeatable, low-morbidity sampling.
Pipeline & Workflow Integration
EBUS-TBNA integrates into discovery workflows as a minimally invasive sampling tool for mediastinal targets, bridging imaging detection with molecular characterization in thyroid-related research.
- Discovery Biology: Enables hypothesis-driven tissue procurement from substernal lesions to validate targets and clarify disease mechanisms.
- Screening: Delivers standardized biopsy samples suitable for high-content analysis and assay validation in thyroid pathology models.
- Analytics: Provides cytological and histological readouts that support quantitative comparison of lesion characteristics across experimental conditions.
- Translational Research: Connects imaging-defined lesions with histopathological confirmation, supporting biomarker translation from discovery to preclinical validation.
- Enterprise Reuse: Represents a platform capability adaptable to various airway-adjacent thoracic targets beyond thyroid lesions.
Operational & Enterprise Impact
- Scientific Value: Enhances target confidence by enabling direct molecular interrogation of anatomically challenging lesions.
- Operational Value: Improves workflow efficiency through same-day procedure completion and rapid cytopathological assessment.
- Strategic Value: Reduces reliance on surgical biopsy, lowering barriers to sample acquisition in high-risk or comorbid models.
- Portfolio Impact: Supports go/no-go decisions by providing timely histopathological data to de-risk thyroid-targeted programs.
Implementation Considerations
- Requires expertise in bronchoscopy and ultrasound-guided needle techniques.
- Dependent on availability of convex probe EBUS systems and transbronchial aspiration needles.
- Necessitates coordination with cytopathology services for timely sample evaluation.
- Requires training to differentiate vascular from parenchymal structures using Doppler ultrasound.
- Limited to lesions accessible via bronchial submucosa, excluding deeply parenchymal or non-airway-adjacent targets.
Biopharma FAQs
Why does EBUS-TBNA support target validation in substernal lesions?
EBUS-TBNA enables tissue sampling from substernal thyroid lesions that are inaccessible to percutaneous biopsy due to overlying sternum, allowing molecular and histopathological analysis to confirm target expression and disease relevance in preclinical models.
How does real-time ultrasound guidance improve sample quality in EBUS-TBNA?
Real-time ultrasound visualization allows precise needle placement within the lesion while avoiding vascular structures, increasing diagnostic yield and reducing sample contamination from blood or adjacent tissues.
What quantitative outputs does EBUS-TBNA enable for assay development?
EBUS-TBNA provides core tissue samples suitable for histological staining, immunohistochemistry, and molecular profiling, generating quantitative data on protein expression, mutation status, and biomarker levels for assay validation.
Why are replication requirements important for EBUS-TBNA in research settings?
Consistent sampling technique across multiple procedures ensures reproducible histopathological and molecular data, which is essential for validating assay performance and minimizing variability in target validation studies.
What statistical analysis is needed before implementing EBUS-TBNA in a discovery workflow?
Implementation requires assessment of sampling success rates, diagnostic sensitivity and specificity, and inter-operator variability to establish performance benchmarks for reliable integration into preclinical screening or validation pipelines.
Chapters in this video
0:05
Title
2:24
The Convex–probe Endobronchial Ultrasound Bronchoscope
4:01
Locating the Lesion of Interest with the Convex–probe Endobronchial Ultrasound Bronchoscope
6:49
Obtaining the Endobronchial Ultrasound–guided Transbronchial Needle Biopsy
9:10
Results: Successful Biopsy and Review of Thyroid tissue
9:34
Conclusion
